Vestal-Point-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
63
Total Value
1400316542
Accession Number
0001974915-25-000005
Form Type
13F-HR
Manager Name
Vestal-Point-Capital-Lp
Data Enrichment
97% identified
61 identified2 unidentified

Holdings

63 positions
Manager:
Search and click to pin securities to the top
Page 3 of 4
Immunovant, Inc.
Shares:350.0K
Value:$6.0M
Zymeworks Inc.
Shares:500.0K
Value:$6.0M
Applied Therapeutics, Inc.
Shares:11.5M
Value:$5.6M
iTeos Therapeutics, Inc.
Shares:900.0K
Value:$5.4M
GALAPAGOS NV
Shares:200.0K
Value:$5.0M
Voyager Therapeutics, Inc.
Shares:1.2M
Value:$4.2M
Lexeo Therapeutics, Inc.
Shares:1.1M
Value:$3.9M
Kiniksa Pharmaceuticals International, plc
Shares:169.9K
Value:$3.8M
Celldex Therapeutics, Inc.
Shares:198.6K
Value:$3.6M
OnKure Therapeutics, Inc.
Shares:635.0K
Value:$2.7M
Ventyx Biosciences, Inc.
Shares:2.0M
Value:$2.3M
Arcturus Therapeutics Holdings Inc.
Shares:211.8K
Value:$2.2M
Passage BIO, Inc.
Shares:6.1M
Value:$2.2M
FATE THERAPEUTICS INC
Shares:2.5M
Value:$2.0M
Alto Neuroscience, Inc.
Shares:915.0K
Value:$2.0M
SUTRO BIOPHARMA, INC.
Shares:2.6M
Value:$1.7M
29286M105
Shares:370.0K
Value:$1.7M
Alector, Inc.
Shares:504.5K
Value:$620.6K
Atara Biotherapeutics, Inc.
Shares:94.1K
Value:$558.9K
Traws Pharma, Inc.
Shares:175.0K
Value:$402.5K